by Gabriel Levitt, President, PharmacyChecker.com and Prescription Justice | Jul 7, 2011 | Advocacy, Drug Prices, Online Pharmacies
Over the past few years we’ve found that, despite many positive ratings from actual consumers, the most reputable and safe international online pharmacies are unfairly given low ratings on WOT. As an online community of people who are supposed to rate websites on their trustworthiness, this is clearly problematic. Last week we posted an article about online pharmacies as a forum discussion on WOT – MyWot.com – to share our analysis of why the best international online pharmacies are wrongly receiving poor reputations. It should be recognized that many dangerous online pharmacies, foreign and domestic, are appropriately rated poorly on WOT, but, as described below, that doesn’t excuse rating good websites as bad.
In summary, a handful of WOT’s “Platinum” raters (those that have provided more than 10,000 ratings) mostly look to the online pharmacy evaluations of LegitScript.com and the National Association of Boards of Pharmacy, both aligned with the interests of big pharmaceutical companies. By doing so, WOT users are serving the commercial interests of the pharmaceutical and U.S. pharmacy industries by giving a low rating to trustworthy and safe online pharmacies. This is wrong and hurts consumers.
Because WOT ratings are used to determine exposure on other sites, unwarranted low ratings of safe and affordable non-U.S. online pharmacies, which are actually trustworthy, can harm American consumers who can’t afford drug prices. Sadly, these low ratings may cause them to forgo needed medication by wrongly believing an affordable online pharmacy is dangerous and untrustworthy when in fact it is very safe and trustworthy.
Since we posted the article as a forum there has been mostly positive feedback (except about the length of the forum) and a frank discussion about online pharmacies, access to medication and Web of Trust.
Tagged with: affordable drugs, LegitScript, mywot.com, National Boards of Pharmacy, Online Pharmacies, platinum rater, ratings, U.S. pharmacy industry, Web of Trust, WOT
by Gabriel Levitt, President, PharmacyChecker.com and Prescription Justice | May 31, 2011 | Drug Importation, Online Pharmacies
Last Thursday, the Senate Judiciary Committee unanimously passed S. 968, Preventing Real Online Threats to Economic Creativity and Theft of Intellectual Property Act of 2011, also known as the Protect IP Act. Its passage represents a real threat to Americans’ access to safe and affordable medications online and we hope that as the bill makes its way through the legislative process it will be amended appropriately.
Essentially, the bill will make it easier to crackdown on rogue pharmacy sites selling fake meds and not requiring a prescription, which is great; however, it will also encourage actions to block Americans’ access to reputable and affordable non-U.S. online pharmacies that sell genuine medication and require a prescription, which are a lifeline for uninsured Americans. That’s because of Section 5, which includes in its definition of “infringing sites” online pharmacies that sell medications to Americans that are not manufactured in a facility approved by the FDA. (more…)
Tagged with: Americans, Australia, Canada, cloture, Demand Progress, Electronic Frontier Foundation, Eli Lily, European Union, fake meds, FDA, First Amendment, GlaxoSmithKline, Google, legislation, Merck, Online Pharmacies, Pfizer, S.968, Senate Judiciary Committee, Senator Wyden, The Protect Intellectual Property Act, UK, United States
by Gabriel Levitt, President, PharmacyChecker.com and Prescription Justice | May 17, 2011 | Online Pharmacies, Personal Drug Importation
A new post on RxRights.org explains how the National Association of Boards of Pharmacy (NABP)’s Internet Drug Outlet Identification Program wrongly misleads consumers and the media by tagging all non-U.S. online pharmacies that sell to Americans as “rogue.” Essentially, that program’s list includes dangerous rogue online pharmacies along with reputable online pharmacies that meet high standards of safety but are simply not based in the United States. American consumers should expect more from pharmacy regulatory authorities and deserve to be properly informed. By adding properly verified international online pharmacies to the list, NABP scares Americans away from safe and affordable sources of medication. RxRight.org alerts the public that NABP’s program was sponsored with a grant from the drug giant Pfizer.
The post also deconstructs the ridiculous notion that only “FDA-approved” drugs are safe. It explains that the same exact drug purchased from a Canadian pharmacy (or any non-U.S. pharmacy) that is sold in the United States is “Not FDA-approved.” How can that be if it’s the same drug? There are many reasons, but one primary reason is labeling. FDA-approved drugs include approval of the drug’s specific labeling. That means that virtually all drugs sold in Canada that are compositionally identical to those sold in the United States are not “FDA-approved” because their labeling is different (such as including information in French and English), but of course they are equally as safe.
PharmacyChecker.com applauds RxRights.org for exposing misinformation campaigns sponsored by the pharmaceutical industry meant to scare Americans away from safe and affordable online pharmacies, wrongly inform the media, and shape our nation’s laws and regulations.
Tagged with: Canada, Canadian pharmacies, drugs from canada, FDA-approved, National Associations of Boards of Pharmacy, Not FDA-approved, Online Pharmacies, Pfizer, rogue pharmacies, RxRights.org, United States
